Novel Tissues Private Limited - Company Profile

It is a manufacturing private limited company based in Bangalore, Karnataka, India, established in 2003.
2003 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Novel Tissues Private Limited

Novel Tissues Private Limited, a active private limited company, was established on 30 July 2003 in Bangalore, Karnataka, India. Engaging in paper & packaging products within the manufacturing sector, it holds CIN: U05190KA2003PTC032338. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.40 M and a paid-up capital of ₹2.40 M.

It upholds a compliant status. Employing 3 professional, Its leadership includes Adaviappa Balappa Doddamani (Director), Lava Basaningappa Doddamani (Director). Past directors included Mohanan Vechiyot, Sabu Varghese Thelappillil, Thankachan Chempotty. It holds ₹32.05 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No.2, First Floor City Point13/7, Infantry Road, Bangalore, Karnataka, 570018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U05190KA2003PTC032338

  • Registration Number

    032338

  • Incorporation Date

    30 July 2003

  • Authorized Capital

    ₹2.40 M

  • Paid-Up Capital

    ₹2.40 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.40 M
  • Paid Up Capital ₹ 2.40 M
  • Company Age 22 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 32.05 Cr
  • Revenue Growth **** 31.91%
  • Profit Growth **** 28.21%
  • Ebitda **** 40.17%
  • Net Worth 31.22%
  • Total Assets **** 47.40%
Company report

Novel Tissues Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novel Tissues Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Novel Tissues Private Limited?
Current Directors
Name Designation Appointment Date Status
Adaviappa Balappa Doddamani Director 08 Sep 2011 Current
Lava Basaningappa Doddamani Director 11 Nov 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 25 Jul 2010 Past
Pramod Abcsdd Director 12 Dec 2008 Past
Pramod Abcsdd Director 12 Dec 2008 Past
Pramod Abcsdd Director 25 Sep 2013 Past
Pramod Abcsdd Director 12 Dec 2008 Past
Pramod Abcsdd Director 11 Jan 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novel Tissues.

Novel Tissues Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.91% increase. The company also saw a substantial improvement in profitability, with a 28.21% increase in profit. The company's net worth Soared by an impressive increase of 31.22%.

Novel Tissues revenue growth over time
Novel Tissues profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 31.91%
*******
*******
*******
*******
Revenue from Operations
*******
 31.79%
*******
*******
*******
*******
Total Assets
*******
 47.40%
*******
*******
*******
*******
Profit or Loss
*******
 28.21%
*******
*******
*******
*******
Net Worth
*******
 31.22%
*******
*******
*******
*******
EBITDA
*******
 40.17%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novel Tissues?

In 2023, Novel Tissues had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹320,510,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sidbi : 26.45 Cr
  • Canara Bank : 5.57 Cr
  • The Canara Bank Ltd : 0.03 Cr
Latest Charge Details
Date Lender Amount Status
19 Mar 2025 Sidbi ₹2.00 Cr Open
28 Jun 2024 Sidbi ₹5.95 Cr Open
28 Jun 2024 Sidbi ₹2.00 Cr Open
21 Mar 2023 Canara Bank ₹6.00 M Open
16 Jun 2022 Sidbi ₹6.95 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Novel Tissues?

Novel Tissues has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novel Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Tissues's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novel Tissues
Recent Activity within the Organization
  • Charges

    Progress on A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 101077732 was registered on 19 Mar 2025. was documented.

  • Charges

    A charge with Sidbi amounted to Rs. 59.50 M with Charge ID 100951228 was registered on 28 Jun 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100951097 was registered on 28 Jun 2024. was documented.

  • Annual General Meeting

    The activity Novel Tissues Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Novel Tissues Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 6.00 M with Charge ID 100749385 was registered on 21 Mar 2023. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novel Tissues Private Limited?

The CIN of Novel Tissues Private Limited is U05190KA2003PTC032338.

Where is Novel Tissues Private Limited headquartered?

Novel Tissues Private Limited is headquartered at No.2, First Floor City Point13/7, Infantry Road, Bangalore, Karnataka, 570018.

When was Novel Tissues Private Limited incorporated?

Novel Tissues Private Limited was incorporated on 30 July 2003.

Who are the current directors of Novel Tissues Private Limited?

The current directors of Novel Tissues Private Limited are

What is the primary industry of Novel Tissues Private Limited?

The primary industry of Novel Tissues Private Limited is Manufacturing.

Is Novel Tissues Private Limited a listed company?

Novel Tissues Private Limited is unlisted.

What is the capital structure of Novel Tissues Private Limited?

The authorized capital of Novel Tissues Private Limited is ₹2.40 M, and the paid-up capital is ₹2.40 M.

What is the compliance status of Novel Tissues Private Limited?

The compliance status of Novel Tissues Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available